These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18607151)

  • 1. The metabolic syndrome and cardiovascular disease: Part I.
    Jiamsripong P; Mookadam M; Honda T; Khandheria BK; Mookadam F
    Prev Cardiol; 2008; 11(3):155-61. PubMed ID: 18607151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds.
    Grundy SM
    J Am Coll Cardiol; 2006 Mar; 47(6):1093-100. PubMed ID: 16545636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome, inflammation and atherosclerosis.
    Paoletti R; Bolego C; Poli A; Cignarella A
    Vasc Health Risk Manag; 2006; 2(2):145-52. PubMed ID: 17319458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dysmetabolic syndrome, insulin resistance and increased cardiovascular (CV) morbidity and mortality in type 2 diabetes: aetiological factors in the development of CV complications.
    Eschwège E
    Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S19-27. PubMed ID: 14502097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mannose-binding lectin in obesity with different degrees of metabolic syndrome abnormalities: association with atherogenic and metabolic traits.
    Strack C; Baessler A; Wagner F; Bruxmeier J; Yaroslavskii O; Rousseva E; Loew T; Riegger G; Schmitz G; Fischer M
    J Atheroscler Thromb; 2012; 19(6):539-51. PubMed ID: 22472212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome: therapeutic considerations.
    Grundy SM
    Handb Exp Pharmacol; 2005; (170):107-33. PubMed ID: 16596797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin and Cardiovascular Risk. From Pathophysiology to Clinic: Focus on Children and Adolescents.
    Orlando A; Nava E; Giussani M; Genovesi S
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31262082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between metabolic syndrome components and the development of atherosclerosis.
    Aboonabi A; Meyer RR; Singh I
    J Hum Hypertens; 2019 Dec; 33(12):844-855. PubMed ID: 31636352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardiovascular continuum in Asia--a new paradigm for the metabolic syndrome.
    Cheung BM
    J Cardiovasc Pharmacol; 2005 Aug; 46(2):125-9. PubMed ID: 16044022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation.
    Lechner K; McKenzie AL; Kränkel N; Von Schacky C; Worm N; Nixdorff U; Lechner B; Scherr J; Weingärtner O; Krauss RM
    Metab Syndr Relat Disord; 2020 May; 18(4):176-185. PubMed ID: 32119801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome: a marker of patients at high cardiovascular risk.
    Lau DC; Yan H; Dhillon B
    Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):85B-90B. PubMed ID: 16498518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipokine Dysregulation and Insulin Resistance with Atherosclerotic Vascular Disease: Metabolic Syndrome or Independent Sequelae?
    Satish M; Saxena SK; Agrawal DK
    J Cardiovasc Transl Res; 2019 Oct; 12(5):415-424. PubMed ID: 30835048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the metabolic syndrome? Prediabetes and cardiovascular risk.
    Borgman M; McErlean E
    J Cardiovasc Nurs; 2006; 21(4):285-90. PubMed ID: 16823282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift.
    Nolan CJ; Prentki M
    Diab Vasc Dis Res; 2019 Mar; 16(2):118-127. PubMed ID: 30770030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hypertension in the metabolic syndrome: who is affected?
    Velarde G; Berk BC
    Curr Hypertens Rep; 2005 Dec; 7(6):418-26. PubMed ID: 16386197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary regulation of glucose metabolism in metabolic syndrome.
    Bulló M; Cózar-Torrell P; Salas-Salvadó J
    Curr Vasc Pharmacol; 2013 Nov; 11(6):928-45. PubMed ID: 24168442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome: controversial but useful.
    Stolar M
    Cleve Clin J Med; 2007 Mar; 74(3):199-202, 205-8. PubMed ID: 17375800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifestyle modification and endothelial function in obese subjects.
    Hamdy O
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A major health hazard: the metabolic syndrome.
    Isomaa B
    Life Sci; 2003 Sep; 73(19):2395-411. PubMed ID: 12954449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of increased cardiovascular disease in obesity and metabolic syndrome.
    Vazzana N; Santilli F; Sestili S; Cuccurullo C; Davi G
    Curr Med Chem; 2011; 18(34):5267-80. PubMed ID: 22087824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.